-
PERIOD PREVALENCE OF MAJOR COMORBIDITIES FOLLOWING THE DIAGNOSIS OF GRAVES’ DISEASE: A NATIONWIDE COHORT STUDY IN SOUTH KOREA
Mar 18, 2026, 21:38 PM -
DEMOGRAPHIC DISPARITIES IN OPIOID USE DISORDER AND TREATMENT ACCESS DURING PREGNANCY AMONG KENTUCKY MEDICAID BENEFICIARIES
Mar 18, 2026, 21:38 PM -
HEALTH TECHNOLOGY ASSESSMENT OF LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEMS IN INDIA: EVIDENCE FROM NETWORK META-ANALYSIS AND COST-EFFECTIVENESS MODELLING
Mar 18, 2026, 21:38 PM -
UNDERSTANDING THE HUMANISTIC BURDEN OF SJÖGREN’S DISEASE (SJD): A SYSTEMATIC LITERATURE REVIEW (SLR)
Mar 18, 2026, 21:38 PM -
ASSESSING SELF-REPORTED HEALTH AND QUALITY OF LIFE IN ETHNICALLY DIVERSE CAREGIVERS FOR PEOPLE WITH AGITATION IN ALZHEIMER'S DEMENTIA
Mar 18, 2026, 21:38 PM -
A MICROCOSTING STUDY OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH) BASED ON REAL WORLD DATA FROM BRAZIL
Mar 18, 2026, 21:38 PM -
ASSOCIATIONS BETWEEN SOCIAL MEDIA USAGE MOTIVATIONS, DEPENDENCY, AND OFFLINE SOCIAL OUTCOMES
Mar 18, 2026, 21:38 PM -
ASSESSING GENERIC PREFERENCE-BASED MEASURES FOR PROGRESSIVE SUPRANUCLEAR PALSY: A CONCEPT MAPPING APPROACH
Mar 18, 2026, 21:38 PM -
USE OF A NEW INSTRUMENT TO ASSESS HEALTH-RELATED QUALITY OF LIFE IN CHILDREN 0-3 YEARS OF AGE DURING HOSPITALIZATION DUE TO ROTAVIRUS GASTROENTERITIS IN THE US
Mar 18, 2026, 21:38 PM -
ARE MEDICARE’S NEGOTIATED PRICES FOR APIXABAN AND RIVAROXABAN CONSISTENT WITH VALUE BASED PRICES? EVIDENCE FROM A SYSTEMATIC REVIEW OF U.S. COST-EFFECTIVENESS ANALYSES
Mar 18, 2026, 21:38 PM -
REAL-WORLD EVIDENCE METHODOLOGY FOR ECONOMIC EVALUATION OF CLINICAL AI: COST-EFFECTIVENESS OF AN IMAGING ALGORITHM FOR INCIDENTAL DETECTION OF EMPHYSEMA
Mar 18, 2026, 21:38 PM -
HEALTH CARE UTILIZATION DIFFERENCES BETWEEN MEDICARE ADVANTAGE AND STANDALONE PART D PLANS IN MEDICARE BENEFICIARIES WITH CANCER
Mar 18, 2026, 21:38 PM -
REAL-WORLD UTILIZATION-INFORMED, ROUTE-STRATIFIED OPTIMIZATION OF IVIG/SCIG SELECTION TO IMPROVE INFUSION-CENTER THROUGHPUT
Mar 18, 2026, 21:38 PM -
POST-MARKETING SAFETY PROFILE OF ANTIDEPRESSANTS IN 2012 TO 2025
Mar 18, 2026, 21:38 PM -
OPIOID TAPERING AND RISK OF CARDIOVASCULAR DISEASES AMONG OLDER ADULTS: A CASE-CROSSOVER STUDY
Mar 18, 2026, 21:38 PM -
IDENTIFYING TENOSYNOVIAL GIANT CELL TUMOR (TGCT) IN SECONDARY DATA: METHODOLOGICAL CHALLENGES, EMERGING OPPORTUNITIES, AND FUTURE DIRECTIONS
Mar 18, 2026, 21:38 PM -
CAN NEIGHBORHOOD-LEVEL SOCIAL DETERMINANTS OF HEALTH MEASURES IMPROVE MACHINE LEARNING CLASSIFICATION TASKS? DETECTING ALCOHOL USE DISORDER AS A USE CASE
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF GLUCAGON-LIKE PEPTIDE-1 VERSUS BARIATRIC SURGERY IN THE MANAGEMENT OF OBESITY: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
TREATMENT AND RECURRENCE PATTERNS AMONG BACILLUS CALMETTE-GUÉRIN EXPERIENCED PATIENTS WITH RECURRENT, PAPILLARY-ONLY HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER
Mar 18, 2026, 21:38 PM -
UNDERSTANDING THE IMPACT AND BURDEN OF MENOPAUSE ON MULTIPLE SCLEROSIS THROUGH A TARGETED LITERATURE REVIEW
Mar 18, 2026, 21:38 PM
